Logo image of JBOG.PA

JACQUES BOGART (JBOG.PA) Stock Fundamental Analysis

EPA:JBOG - Euronext Paris - Matif - FR0012872141 - Common Stock - Currency: EUR

5.05  -0.15 (-2.88%)

Fundamental Rating

2

JBOG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 12 industry peers in the Personal Care Products industry. Both the profitability and financial health of JBOG have multiple concerns. JBOG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JBOG had negative earnings in the past year.
In the past year JBOG had a positive cash flow from operations.
In multiple years JBOG reported negative net income over the last 5 years.
Each year in the past 5 years JBOG had a positive operating cash flow.
JBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFJBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

JBOG has a Return On Assets of -0.11%. This is amonst the worse of the industry: JBOG underperforms 83.33% of its industry peers.
With a Return On Equity value of -0.54%, JBOG is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
JBOG's Return On Invested Capital of 4.63% is on the low side compared to the rest of the industry. JBOG is outperformed by 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBOG is significantly below the industry average of 12.75%.
The 3 year average ROIC (3.93%) for JBOG is below the current ROIC(4.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.11%
ROE -0.54%
ROIC 4.63%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
JBOG.PA Yearly ROA, ROE, ROICJBOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

JBOG's Operating Margin of 5.53% is on the low side compared to the rest of the industry. JBOG is outperformed by 91.67% of its industry peers.
In the last couple of years the Operating Margin of JBOG has remained more or less at the same level.
JBOG has a Gross Margin (52.81%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of JBOG has grown nicely.
Industry RankSector Rank
OM 5.53%
PM (TTM) N/A
GM 52.81%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
JBOG.PA Yearly Profit, Operating, Gross MarginsJBOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

JBOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
JBOG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, JBOG has less shares outstanding
The debt/assets ratio for JBOG is higher compared to a year ago.
JBOG.PA Yearly Shares OutstandingJBOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JBOG.PA Yearly Total Debt VS Total AssetsJBOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that JBOG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.41, JBOG is doing worse than 75.00% of the companies in the same industry.
The Debt to FCF ratio of JBOG is 8.03, which is on the high side as it means it would take JBOG, 8.03 years of fcf income to pay off all of its debts.
JBOG's Debt to FCF ratio of 8.03 is on the low side compared to the rest of the industry. JBOG is outperformed by 83.33% of its industry peers.
A Debt/Equity ratio of 2.09 is on the high side and indicates that JBOG has dependencies on debt financing.
With a Debt to Equity ratio value of 2.09, JBOG is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 8.03
Altman-Z 1.41
ROIC/WACC0.78
WACC5.95%
JBOG.PA Yearly LT Debt VS Equity VS FCFJBOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

JBOG has a Current Ratio of 1.25. This is a normal value and indicates that JBOG is financially healthy and should not expect problems in meeting its short term obligations.
JBOG has a better Current ratio (1.25) than 66.67% of its industry peers.
JBOG has a Quick Ratio of 1.25. This is a bad value and indicates that JBOG is not financially healthy enough and could expect problems in meeting its short term obligations.
JBOG has a Quick ratio of 0.51. This is amonst the worse of the industry: JBOG underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.51
JBOG.PA Yearly Current Assets VS Current LiabilitesJBOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

0

3. Growth

3.1 Past

JBOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.68%.
JBOG shows a decrease in Revenue. In the last year, the revenue decreased by -1.29%.
JBOG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.99% yearly.
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.99%
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-0.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBOG.PA Yearly Revenue VS EstimatesJBOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBOG.PA Yearly EPS VS EstimatesJBOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 0.1 0.2 0.3 0.4 0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBOG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBOG.PA Price Earnings VS Forward Price EarningsJBOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBOG indicates a rather cheap valuation: JBOG is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JBOG indicates a rather cheap valuation: JBOG is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3
EV/EBITDA 5.13
JBOG.PA Per share dataJBOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

JBOG has a Yearly Dividend Yield of 3.08%. Purely for dividend investing, there may be better candidates out there.
JBOG's Dividend Yield is a higher than the industry average which is at 2.57.
Compared to an average S&P500 Dividend Yield of 2.38, JBOG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.08%

5.2 History

The dividend of JBOG has a limited annual growth rate of 0.04%.
Dividend Growth(5Y)0.04%
Div Incr Years1
Div Non Decr Years2
JBOG.PA Yearly Dividends per shareJBOG.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of JBOG are negative and hence is the payout ratio. JBOG will probably not be able to sustain this dividend level.
DP-664.4%
EPS Next 2YN/A
EPS Next 3YN/A
JBOG.PA Yearly Income VS Free CF VS DividendJBOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

JACQUES BOGART

EPA:JBOG (5/30/2025, 7:00:00 PM)

5.05

-0.15 (-2.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-28 2025-04-28
Earnings (Next)09-24 2025-09-24
Inst Owners0.15%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap79.23M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.08%
Yearly Dividend0.2
Dividend Growth(5Y)0.04%
DP-664.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF 3
P/OCF 2.42
P/B 0.97
P/tB 2.06
EV/EBITDA 5.13
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.68
FCFY33.31%
OCF(TTM)2.08
OCFY41.24%
SpS18.46
BVpS5.2
TBVpS2.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -0.54%
ROCE 6.59%
ROIC 4.63%
ROICexc 5.58%
ROICexgc 7.01%
OM 5.53%
PM (TTM) N/A
GM 52.81%
FCFM 9.11%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
ROICexc(3y)4.95%
ROICexc(5y)5.05%
ROICexgc(3y)6.26%
ROICexgc(5y)6.5%
ROCE(3y)5.59%
ROCE(5y)5.24%
ROICexcg growth 3Y12.53%
ROICexcg growth 5Y-0.27%
ROICexc growth 3Y13.27%
ROICexc growth 5Y-1.06%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 8.03
Debt/EBITDA 3.69
Cap/Depr 20.85%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 70.76%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.51
Altman-Z 1.41
F-Score4
WACC5.95%
ROIC/WACC0.78
Cap/Depr(3y)18.79%
Cap/Depr(5y)19.78%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-0.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.4%
EBIT growth 3Y19.99%
EBIT growth 5Y-2.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y146.75%
FCF growth 3Y-5.9%
FCF growth 5Y0.49%
OCF growth 1Y102.88%
OCF growth 3Y-7.79%
OCF growth 5Y0.93%